CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

交易 Indaptus Therapeutics, Inc. - INDP CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024874%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.002651%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 1.25-4.19
平均交易量(10 天) 9,410.00
平均交易量(3 个月) 171.47K
市值 14.87M
市盈率 -100.00K
流通股 8.40M
收入 N/A
EPS -1.73
股息(收益率 %) N/A
贝塔 1.19
下一个财报发布日期 N/A

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Indaptus Therapeutics, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2022 2021 2020 2019 2018
总收入 0 0 0 0 0
收入
总营业费用 14.9109 7.72911 13.829 47.109 43.328
销售/一般/行政费用,总计 8.58625 5.20596 7.089 8.287 7.926
研究与开发 6.32466 2.52315 6.74 26.659 35.402
Depreciation / Amortization
利息费用(收入) - 净运营
Other Operating Expenses, Total 0 -1.5
营业收入 -14.9109 -7.72911 -13.829 -47.109 -43.328
利息收入(费用),非经营净值 0.01772 -0.165 0.163 -0.089
税前净收入 -14.3228 -7.71139 -14.004 -46.961 -43.44
税后净收入 -14.3228 -7.71139 -14.128 -47.599 -43.543
未计算非常项目前的净收益 -14.3228 -7.71139 -14.128 -47.599 -43.543
净收入 -14.3228 -7.71139 -14.128 -47.599 -43.543
普通股股东可获收益 (不含非经常性项目) -14.3228 -7.71139 -14.128 -47.599 -43.543
普通股股东可获收益 (含非經常性項目) -14.3228 -7.71139 -14.128 -47.599 -43.543
摊薄净收入 -14.3228 -7.71139 -14.128 -47.599 -43.543
摊薄后加权平均股 8.26212 4.0906 0.86525 0.4222 0.38991
扣除特别项目的每股摊薄盈利 -1.73355 -1.88515 -16.3282 -112.74 -111.674
每股正常摊薄盈利 -1.73355 -1.88515 -16.3282 -91.7055 -111.674
其他,净值 0.58811 -0.01 -0.015 -0.023
异常费用(收入) 0 13.663
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
总收入 0 0 0 0 0
总营业费用 4.08702 3.55255 3.86926 3.40207 3.2185
销售/一般/行政费用,总计 2.17518 1.943 2.3631 2.10498 2.27386
研究与开发 1.91184 1.60955 1.50617 1.2971 0.94464
营业收入 -4.08702 -3.55255 -3.86926 -3.40207 -3.2185
其他,净值 0.43125 0.08618 0.03376 0.03692
税前净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
税后净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
未计算非常项目前的净收益 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
普通股股东可获收益 (不含非经常性项目) -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
普通股股东可获收益 (含非經常性項目) -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
摊薄净收入 -3.65578 -3.46637 -3.8355 -3.36515 -3.21632
摊薄后加权平均股 8.27269 8.2586 8.2586 8.2586 8.28409
扣除特别项目的每股摊薄盈利 -0.44191 -0.41973 -0.46443 -0.40747 -0.38825
Dividends per Share - Common Stock Primary Issue 0 0 0
每股正常摊薄盈利 -0.44191 -0.41973 -0.46443 -0.40747 -0.38825
利息收入(费用),非经营净值 0.00217
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 40.3872 14.968 13.745 43.565 56.343
现金和短期投资 39.1322 14.671 10.062 40.579 55.218
现金等价物 39.1322 14.671 9.292 39.246 53.393
短期投资 0.77 1.333 1.825
应收账款总额,净额 0.085 3.486 2.031 0.478
Accounts Receivable - Trade, Net 0.085 3.486 2.031 0.478
Other Current Assets, Total 0.1484
Total Assets 40.5766 20.896 21.28 61.51 64.549
Property/Plant/Equipment, Total - Net 0.17289 2.211 3.818 12.233 8.206
Total Current Liabilities 4.60414 5.334 8.342 7.656 5.747
Payable/Accrued 4.50768 0.368 3.507 2.849 1.854
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 4.37 4.835 0.02 0.033
Total Liabilities 4.677 6.363 9.745 7.965 5.747
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.07286 1.029 1.403 0.309 0
Total Equity 35.8996 14.533 11.535 53.545 58.802
Common Stock 0.08259 0.727 0.727 0.727 0.727
Additional Paid-In Capital 51.4879 217.357 200.231 194.642 156.356
Retained Earnings (Accumulated Deficit) -15.6709 -203.551 -189.423 -141.824 -98.281
Other Equity, Total
Total Liabilities & Shareholders’ Equity 40.5766 20.896 21.28 61.51 64.549
Total Common Shares Outstanding 8.2586 1.08032 0.44865 0.41541 0.32595
Prepaid Expenses 1.10665 0.212 0.197 0.955 0.647
Property/Plant/Equipment, Total - Gross 10.61 11.014 18.575 13.689
Accumulated Depreciation, Total -8.399 -7.196 -6.342 -5.483
Other Long Term Assets, Total 0.01648 3.717 3.717 5.712 0
Accrued Expenses 0.09647 0.596 4.787 3.86
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 36.9197 40.3872 43.8549 18.792 12.159
现金和短期投资 36.1778 39.1322 41.8572 16.991 10.135
现金等价物 33.2163 39.1322 41.8572 16.991 10.135
Prepaid Expenses 0.74195 1.10665 1.39767 0.801 1.024
Other Current Assets, Total 0 0.1484 0.6 1 1
Total Assets 37.0866 40.5766 43.8592 20.092 17.43
Property/Plant/Equipment, Total - Net 0.15037 0.17289 0.00434 0 1.554
Other Long Term Assets, Total 0.01648 0.01648 1.3 3.717
Total Current Liabilities 3.67966 4.60414 5.78018 5.44 5.203
Payable/Accrued 0.40032 4.50768 5.78018 0.397 0.183
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 5.043 5.02
Total Liabilities 3.73017 4.677 5.78018 6.156 6.086
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.05052 0.07286 0.716 0.883
Total Equity 33.3564 35.8996 38.079 13.936 11.344
Common Stock 0.08259 0.08259 0.08133 0.727 0.727
Additional Paid-In Capital 52.3191 51.4879 50.4523 228.421 218.397
Retained Earnings (Accumulated Deficit) -19.036 -15.6709 -12.4546 -215.212 -207.78
Total Liabilities & Shareholders’ Equity 37.0866 40.5766 43.8592 20.092 17.43
Total Common Shares Outstanding 8.2586 8.2586 8.13324 1.85874 1.12565
Accrued Expenses 0.44466 0.09647
短期投资 2.96146
Accounts Payable 2.83468
Other Equity, Total -0.00922
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -7.71139 -14.128 -47.599 -43.543 -28.909
经营活动产生的现金 -11.2905 -11.511 -29.045 -39.076 -22.132
经营活动产生的现金 0.0014 1.203 0.854 0.859 0.829
非现金物品 1.49378 1.001 17.192 4.25 0.858
营运资金的变化 -5.07433 0.413 0.508 -0.642 5.09
投资活动产生的现金 0.44775 0.75 -3.21 -9.301 -4.747
资本支出 -0.00385 -0.022 -0.921 -4.667 -5.001
其他投资现金流量项目,总计 0.4516 0.772 -2.289 -4.634 0.254
融资活动产生的现金 48.3375 15.978 2.368 35.059 63.707
股票的发行(报废),净额 27.6565 15.907 2.368 35.059 63.707
外汇效应 0.162 -0.067 -0.829 0.127
现金净变化 37.4947 5.379 -29.954 -14.147 36.955
Cash Taxes Paid 0.0008 0.009 0.075 0.096 0
融资现金流项目 20.681 0.071
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -3.36515 -7.71139 -4.49506 -11.661 -0.61242
Cash From Operating Activities -3.11773 -11.2905 -7.75082 -7.397 -0.82558
Cash From Operating Activities 0.00053 0.0014 0.00087 1.178 0.00021
Non-Cash Items 0.80703 1.49378 0.83646 3.493 0.02045
Cash Taxes Paid 0 0.0008 0.0008 0.01 0.0008
Changes in Working Capital -0.56014 -5.07433 -4.09308 -0.407 -0.23382
Cash From Investing Activities -2.79813 0.44775 -0.00385 0 0
Other Investing Cash Flow Items, Total -2.79813 0.4516 0 0
Cash From Financing Activities 0 48.3375 47.9744 10.856 3.675
Financing Cash Flow Items 0 20.681 20.681 3.675
Net Change in Cash -5.91585 37.4947 40.2197 3.32 2.84942
Capital Expenditures -0.00385 -0.00385 0
Issuance (Retirement) of Stock, Net 27.6565 27.2934 10.856
Foreign Exchange Effects -0.139
投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
Newman (Michael James) Individual Investor 16.2879 1368356 0 2022-08-03 LOW
Anderson (Glen R) Individual Investor 12.9394 1087048 348956 2022-07-07 MED
Lee (Hoonmo) Individual Investor 8.2671 694522 0 2021-09-29
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.98 250348 101 2022-12-31 LOW
The Investment House LLC Investment Advisor 1.1383 95629 0 2022-12-31 LOW
Meckler (Jeffrey A) Individual Investor 0.8972 75374 10000 2022-11-21 LOW
Strategy Asset Managers, L.L.C. Investment Advisor 0.6587 55336 0 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.6014 50521 -101 2022-12-31 LOW
Stratos Wealth Partners, Ltd. Investment Advisor 0.3194 26832 0 2022-12-31 LOW
Vivaldi Capital Management, LLC Investment Advisor/Hedge Fund 0.2857 24000 0 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2318 19473 0 2022-12-31 LOW
Renaissance Technologies LLC Hedge Fund 0.2274 19100 -600 2022-12-31 HIGH
Susquehanna International Group, LLP Investment Advisor 0.1725 14495 14495 2022-12-31 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1141 9587 0 2022-12-31 LOW
Tower Research Capital LLC Hedge Fund 0.0803 6742 6418 2022-12-31 HIGH
Northern Trust Global Investments Investment Advisor 0.0394 3311 0 2022-12-31 LOW
Litchev (Boyan Vesselinov) Individual Investor 0.0137 1150 500 2022-12-01 HIGH
Maddaluna (Anthony J) Individual Investor 0.008 670 0 2022-08-03 LOW
Bangor Savings Bank Bank and Trust 0.0048 400 0 2022-12-31 LOW
Morgan Stanley & Co. LLC Research Firm 0.0043 365 0 2022-12-31 MED

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Indaptus Therapeutics, Inc. Company profile

关于 Indaptus Therapeutics Inc.

Indaptus Therapeutics公司,前身为Intec Parent公司,提供免疫疗法来治疗疾病。 该公司致力于开发临床前的候选治疗药物,以产生抗肿瘤和抗病毒反应并治愈疾病。 它通过瞄准特定的肿瘤或病毒抗原来设计其方法。 其主要候选药物Decoy20正处于临床前开发阶段。 其平台是基于这样的假设:要求抗肿瘤免疫疗法同时激活肿瘤和免疫器官的先天和适应性细胞免疫。 其方法是使用多靶点的细菌病原体相关分子模式(PAMPs)包,以减弱和杀死的形式,将完整但不致病的细菌静脉注射。 它的静脉治疗候选药物针对肝脏、脾脏和肿瘤的渗漏血管,在一个免疫器官中产生免疫激活,以及原发性和转移性癌症和乙型肝炎病毒(HBV)感染的共同部位。

Industry: Biotechnology & Medical Research (NEC)

3 Columbus Circle
15Th Floor
10019

收入报表

  • Annual
  • Quarterly

人们也观看

Gold

1,969.66 Price
-0.550% 1D Chg, %
多头隔夜费 -0.0185%
空头隔夜费 0.0102%
隔夜费时间 21:00 (UTC)
价差 0.30

US100

13,186.80 Price
+1.680% 1D Chg, %
多头隔夜费 -0.0249%
空头隔夜费 0.0027%
隔夜费时间 21:00 (UTC)
价差 3.0

Natural Gas

2.20 Price
+3.540% 1D Chg, %
多头隔夜费 -0.4092%
空头隔夜费 0.3873%
隔夜费时间 21:00 (UTC)
价差 0.005

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
多头隔夜费 -0.0156%
空头隔夜费 -0.0063%
隔夜费时间 21:00 (UTC)
价差 0.03

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易